Chlorogenic acid is under clinical development by Sichuan J.Z. Bio-chemical Science and Technology Development and currently in Phase II for Non ... a proprietary algorithm to process data points from ...

Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Head And Neck Cancer.

The Master ́s Programme in Pharmaceutical Research, Development and Safety takes two years of full-time studies to complete. The academic activities conducted based on a personal study plan sum 120 ...